Caglar Cekic
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Purinergic ecto-enzyme CD73 is a context-dependent tumor suppressor in colorectal cancer.
Journal: The Journal of biological chemistry
Published: December 04, 2024
Interleukin-7 protects CD8+ T cells from adenosine-mediated immunosuppression.
Journal: Science signaling
Published: March 17, 2021
Targeting Adenosine with Adenosine Deaminase 2 to Inhibit Growth of Solid Tumors.
Journal: Cancer research
Published: January 31, 2021
Ecto-5'-Nucleotidase (CD73) Regulates the Survival of CD8+ T Cells.
Journal: Frontiers in cell and developmental biology
Published: December 28, 2020
Modulation of myeloid cells by adenosine signaling.
Journal: Current opinion in pharmacology
Published: June 23, 2020
The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8+ T-cell Responses and Promotes Tumor Growth.
Journal: Cancer immunology research
Published: October 23, 2019
Adenosine Receptor Signaling Targets Both PKA and Epac Pathways to Polarize Dendritic Cells to a Suppressive Phenotype.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 05, 2019
Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 24, 2017
Purinergic regulation of the immune system.
Journal: Nature reviews. Immunology
Published: March 01, 2016
Patrolling monocytes control tumor metastasis to the lung.
Journal: Science (New York, N.Y.)
Published: July 01, 2015
Adenosine A2A receptors intrinsically regulate CD8+ T cells in the tumor microenvironment.
Journal: Cancer research
Published: October 25, 2014
Last Updated: 09/26/2026